企業プロフィール
GeoVax Labs 株価・ニュース・カタリスト
- ティッカー:
- GOVX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.66 USD (-8.77%)
終値
最終更新: 2026年8月17日
10.9M USD
時価総額
株価変動の要因
As of Aug 17, 2026, GOVX closed down 8.77% at $0.6550. No new same-company headline was identified in the current news window.
企業概要
事業概要
GeoVax Labs is a biotechnology company developing vaccines and immunotherapies using a virus-like particle platform. Its story is built around infectious disease and oncology programs that seek to create targeted immune responses.
所在地とセクター分類
GeoVax is headquartered in the United States and listed on NASDAQ. It sits in small-cap vaccine and immunotherapy biotechnology.
ビジネスモデルの特徴
The company depends on clinical and preclinical progress, partner interest, and capital efficiency to advance its platform. Investors watch vaccine updates, oncology programs, and whether the platform can produce differentiated immune responses.
バイオ業界での位置付け
GeoVax occupies a niche vaccine-and-immunotherapy position within biotech. It is a catalyst-driven small-cap name where platform validation matters more than commercial scale.
今後のカタリスト
- GeoVax’s catalysts are vaccine and immunotherapy programs, plus any clinical or partnering step that keeps the platform relevant. The company still needs human proof.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。